Pharmaceutical and Supply Chain Integrity for Hospitals — Four-Part Virtual Series

Session 1 — Wednesday, Aug. 7

10 to 11 a.m. — Best Practices in Health Care Supply Chain Management

Jim Eckler
Adjunct Faculty Member
Department of Supply Chain Management
W. P. Carey School of Business
Arizona State University
Tempe, Ariz.

Eugene S. Schneller, Ph.D.
Professor/Dean’s Council of 100 Distinguished Scholar
Department of Supply Chain Management
Arizona State University
Tempe, Ariz.

Session Overview
This session will review best practices learned related to pharmacy supply chain management during COVID-19 and in other responses, and to share how leading systems are ensuring that sufficient pharmacy supplies are on hand while preventing product expiration. Different management structures will be discussed at the hospital level, consolidated service center level and systems level.

Objectives
At the conclusion of this session, participants will be able to:

• outline the changes that have occurred since 2020 on health care supply chain integrity and management
• review lessons learned and best practices related to the use of supply and pharmaceutical caches and how to prevent product expiration
• examine lessons learned and best practices related to inventory management strategies to have sufficient supply on hand

Session 2 — Wednesday, Aug. 14

10 to 11 a.m. — Supply Chain Process Improvement

Kari DiCianni
CCI Analyst
Silver Dollar City
Branson, Mo.

Session Overview
This session will review concepts of process improvement that can be applied to pharmaceutical and supply chain management in hospitals to improve the resiliency of supplies, reduce cost and increase efficiencies.

Objectives
At the conclusion of this session, participants will be able to:

• explain concepts of process improvement in the pharmaceutical supply chain
• summarize how process improvement can be applied to pharmaceutical and supply chains

Session 3 — Wednesday, Aug. 21

10 to 11 a.m. — Supply Chain Considerations During Disruptions and Disasters

Linda Rouse O’Neill
Senior Vice President, Supply Chain Policy
Health Industry Distributors Association
Alexandria, Va.

Tim House
National Vice President of Sales
Concordance Healthcare Solutions
Tiffin, Ohio

Session Overview
This session will discuss special considerations for pharmaceutical and supply management during emergencies and shortages, including forecasting, understanding allocation and vendor relationships. During these incidents, it is important to have a multidisciplinary team addressing supply and pharmaceutical issues and the associated operational and patient care impacts. The session will explore potential individuals to have on that team and why.

Objectives
At the conclusion of this session, participants will be able to:

• explain the impact of shortages and emergencies on pharmaceuticals, equipment and supplies
• describe the allocation process
• outline forecasting shortages and mitigation strategies that can be taken
• evaluate the importance of developing vendor relationships and interprofessional teams to address pharmaceuticals and supplies during shortages and emergencies

Session 4 — Wednesday, Sept. 4

10 to 11 a.m. — Supply Chain Disruption in Missouri Hospitals

Steve Hoeger, CHEP
Corporate Director of Emergency Management
University Health – Truman Medical Centers
Kansas City, Mo.

Greg Teale, PharmD, BCPS
Vice President of Pharmacy Services
Saint Luke’s Division of BJC HealthCare
Kansas City, Mo.

Session Overview
This session will provide real-world examples of both supply and pharmaceutical shortages that hospitals experienced, steps hospitals took to respond and lessons they learned.

Objectives
At the conclusion of this session, participants will be able to:

• examine the potential impact to facility operations and patient care during a pharmaceutical shortage
• implement best practices into your facility pharmaceutical supply chain operations and planning

Kari DiCianni has an extensive background with experience in process improvement, previously managing process improvement for CoxHealth in Branson and Springfield. Along with her experience at CoxHealth, DiCianni also worked in process improvement for Dana Corporation, a direct supplier of Toyota USA. As an expert in the Toyota Production System, DiCianni evaluates current processes and then steers the team through problem-solving techniques to come up with a new process that eliminates the waste and cost in a process, while providing excellent quality to the customer. DiCianni spends her personal time with her husband, William, and owns Rocco’s Pizza in Branson.

Jim Eckler, MS, provides advisory services in the supply chain management field, delivering practical strategic and operational advice to his clients. His background includes over 45 years of experience in supply chain management, outsourcing, business strategy and corporate governance, with a particular specialization in the health care field.

In 2014, he co-founded Healthcare Supply Chain Excellence, as well as Physicians for Supply Chain Excellence, an advisory organization to help physician leaders gain clinical alignment on supply chain matters. He serves as an adjunct faculty member in the Supply Chain Management Department of the W. P. Carey School of Business at Arizona State University. Prior to that, for 20 years, Eckler held senior executive roles in operating companies focused on supply chain management and for 18 years earlier as a supply chain management consultant with Booz Allen and KPMG. During that time, he served as the COO of Health Shared Services BC, an innovative services business providing value-creating solutions to the health care system in British Columbia, Canada. With over 1,800 employees at HSSBC, he provided support services in supply chain management, IT, finance and human resources to all of the health systems in the province using a shared services model of outsourcing.

Eckler is a graduate in mathematics from the University of Waterloo and in management science from the Wharton School of the University of Pennsylvania. He has authored numerous articles on a broad range of supply chain topics and presented to audiences worldwide. He is the co-author of the recently published book, “Strategic Management of the Healthcare Supply Chain.”

Steven Hoeger, CHEP, has served as the Corporate Director of Emergency Management for University Health-Truman Medical Centers in Kansas City, Mo., for the past five years. In addition, he is the chair of the MARC Health Care Coalition.

Tim House has been in the health care industry for the last 15 years. Shortly after completing his MBA in 2012, he wanted to focus his attention on supply chain efficiency and medical product and distribution sales. He has held the title of Vice President at Cardinal Health and Olympus, and has spent his last three years with Concordance Healthcare Solutions. He is currently the Co-chair for the HIDA Acute Care Advisory Council and commits much of his time to advancing people’s careers and helping to shape the future of Concordance, all while keeping health care customers at the forefront. House resides in Scottsdale, Ariz., where he is the father of two daughters, Avery and Jocelyn, and spouse to his wife, Amanda.

Linda Rouse O’Neill is HIDA’s Senior Vice President of Supply Chain Policy. She brings over 30 years of health care-based lobbying, Capitol Hill and member services experience to HIDA. At HIDA, O’Neill oversees the policy and executive branch relations team. HIDA meets with key federal agencies and policymakers on health care issues important to its members, such as pandemic preparedness and response, shipping delays, diversified sourcing, and supply chain resilience. Additionally, the team tracks key reimbursement trends to keep its distributor members and manufacturing partners current on issues facing their customers.

Prior to coming to HIDA, O’Neill spent six years as the director of federal affairs for one of the nation’s largest group purchasing organizations, Premier, Inc., in its Washington, D.C., office. She played a key role in representing the organization before Congress and regulatory agencies. She specialized in Medicare/Medicaid reimbursement, health IT, unique device identification and health care-acquired infections, among other issues. Previously, she spent 4 ½ years as U.S. Sen. Craig Thomas’ (R-WY) health legislative assistant. She advised on, analyzed and wrote health care legislative proposals before the Senate Finance Committee and was a co-staff director for the 80-member Senate Rural Health Caucus.

Eugene Schneller, Ph.D., is a Professor of Supply Chain Management at the W. P. Carey School of Business at Arizona State University. He joined ASU in 1985 and has been a Dean’s Council of 100 Distinguished Scholar since 2007. Prior to ASU, Schneller’s academic appointments were in diverse settings, including business, liberal arts, medicine and public health. His research and consulting focus on health sector supply chain strategy, group purchasing, distribution models and talent development. He has studied public and private health care procurement globally, with a focus on supply chain design, integrity, efficiency and effectiveness. His clients have included Children’s Hospital Association, HCA, CombineMed, FTI, Health Industry Group Purchasing Association, Coastal Carolinas Health Alliance and King Faisal Specialist Hospital and Research Centre. He was principal investigator on the ASU-MEDLOG study to integrate the supply chains of the U.S. armed forces within the Defense Health Agency.

He has served on the editorial review board for the Journal of Supply Chain Management, Healthcare Briefings, Logistics and Hospital Topics. He served on the Board of Directors for the Health Administrators Forum, and chaired the Network for Health Administration Education and the Association of University Programs in Health Administration and the Accrediting Commission on Healthcare Administration. In addition, he served on the Governor’s Council on Telemedicine, pioneering the delivery of health care to diverse populations. He was the commissioner on the California Commission on the Future of Medical Education. He also is the lead author for the authoritative text, “Strategic Management of the Healthcare Supply Chain (2nd ed.).”

Greg Teale, PharmD, BCPS, is Vice President of Pharmacy Services for Saint Luke’s Division of BJC Health Care. He has served as the system pharmacy leader at Saint Luke’s for the past 12 years.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and MHA Health Institute. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

This activity was planned by and for the health care team, and learners will receive 5.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Credit Designation for Pharmacists
This knowledge-based activity is approved for 1.0 contact hour each of continuing pharmacy education credit.

PENDING

AXIS Contact Information
For information about the accreditation of this program, please contact AXIS at info@axismeded.org.

Disclosure of Relevant Financial Relationships
AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, peer reviewers and other individuals who are in a position to control the content of this activity to disclose all personal financial relationships they may have in the past 24 months with ineligible companies. An ineligible entity is any organization whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. All relevant financial relationships are identified and mitigated prior to initiation of the planning phase for an activity.

AXIS has mitigated and disclosed to learners all relevant financial relationships disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.

The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months.

The following directors, planners, managers, peer reviewers and relevant staff reported no financial relationships and no relationships they have with any ineligible company of any amount during the past 24 months.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Requirements for credit:  

• Attend/participate in the educational activity and review all course materials.
• Complete the CE Declaration form online by 11:59 p.m. ET Sept. 30, 2024. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
• Upon successful completion of the online form, your statement of completion will be presented to you to print. For pharmacists, your record will be automatically uploaded to CPE Monitor.

Please note that your registration request will be submitted to the organizer for approval. Upon approval, instructional materials will be sent to the email address indicated on the registration form.

If you have special needs addressed by the Americans With Disabilities Act, please contact the Missouri Hospital Association.

MHA Health Institute
P.O. Box 60
Jefferson City, MO 65102
Phone: 573-893-3700
Fax: 573-893-2809